Abstract
Traumatic experience and posttraumatic stress disorder (PTSD) is highly prevalent among adolescents hospitalized in psychiatric facilities and also among those who are incarcerated. However, it is often not detected in the course of routine evaluations, even those done by mental health professionals. Lack of recognition of trauma exposure and PTSD in hospitalized or incarcerated adolescents has serious implications. The severe behavior problems that result in hospitalizations or incarceration may actually be the result of emotional dysregulation, which is one of the core PTSD problems. This article describes strategies for integrating and evaluating systematic screening, assessment and developmentally appropriate interventions in a public hospital and juvenile justice settings. While research on these interventions is ongoing, preliminary findings have been positive. It is essential that the important role that trauma plays in severe psychopathology be recognized and effectively addressed if we are to help these young people change their trajectory from one of continued victimization to one of effective self-regulation.
Keywords: Traumatic stress, adolescents, inpatients, incarcerated adolescents, screening, posttraumatic stress disorder
Adolescent Psychiatry
Title:Opening Pandora’s Box: The Importance of Trauma Identification and Intervention in Hospitalized and Incarcerated Adolescent Populations
Volume: 2 Issue: 4
Author(s): Jennifer F. Havens, Julian Ford, Damion Grasso and Mollie Marr
Affiliation:
Keywords: Traumatic stress, adolescents, inpatients, incarcerated adolescents, screening, posttraumatic stress disorder
Abstract: Traumatic experience and posttraumatic stress disorder (PTSD) is highly prevalent among adolescents hospitalized in psychiatric facilities and also among those who are incarcerated. However, it is often not detected in the course of routine evaluations, even those done by mental health professionals. Lack of recognition of trauma exposure and PTSD in hospitalized or incarcerated adolescents has serious implications. The severe behavior problems that result in hospitalizations or incarceration may actually be the result of emotional dysregulation, which is one of the core PTSD problems. This article describes strategies for integrating and evaluating systematic screening, assessment and developmentally appropriate interventions in a public hospital and juvenile justice settings. While research on these interventions is ongoing, preliminary findings have been positive. It is essential that the important role that trauma plays in severe psychopathology be recognized and effectively addressed if we are to help these young people change their trajectory from one of continued victimization to one of effective self-regulation.
Export Options
About this article
Cite this article as:
F. Havens Jennifer, Ford Julian, Grasso Damion and Marr Mollie, Opening Pandora’s Box: The Importance of Trauma Identification and Intervention in Hospitalized and Incarcerated Adolescent Populations, Adolescent Psychiatry 2012; 2 (4) . https://dx.doi.org/10.2174/2210676611202040309
DOI https://dx.doi.org/10.2174/2210676611202040309 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery Selective Serotonin Reuptake Inhibitors: A Review of its Effects on Intraocular Pressure
Current Neuropharmacology Conformational Preferences of Aβ25-35 and Aβ35-25 in Membrane Mimicking Environments
Protein & Peptide Letters Mitochondrial Permeability Transition Pore as a Suitable Targ e t for Neuroprotective Agents Against Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Flunarizine Dihydrochloride Nanoemulsion for Migraine Nasal Drug Delivery: Fabrication, Characterization and In Vitro Study
Drug Delivery Letters Scaling Factors for the Extrapolation of In Vivo Metabolic Drug Clearance From In Vitro Data: Reaching a Consensus on Values of Human Micro-somal Protein and Hepatocellularity Per Gram of Liver
Current Drug Metabolism Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review
Current Pharmaceutical Design Review of Computer-Aided Models for Predicting Collagen Stability
Current Computer-Aided Drug Design Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease
Current Radiopharmaceuticals Kv1.3 Lymphocyte Potassium Channel Inhibition as a Potential Novel Therapeutic Target in Acute Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Meet Our Editorial Board Member
Current Neuropharmacology Humanin Nanoparticles for Reducing Pathological Factors Characteristic of Age-Related Macular Degeneration
Current Drug Delivery Supplementation of Milky Flavors Improves the Reproductive Performance and Gut Function Using Sow Model
Protein & Peptide Letters Predictive Genomics DNA Profiling for Athletic Performance
Recent Patents on DNA & Gene Sequences Depression Associated with Diabetes: From Pathophysiology to Treatment
Current Diabetes Reviews Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis
Current HIV Research Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease
Current Pharmaceutical Design Denervation of the Olfactory Bulb Leads to Decreased Aβ Plaque Load in a Transgenic Mouse Model of Alzheimer’ s Disease
Current Alzheimer Research Using Metabolomics for Elucidating the Mechanisms Related to Tuberculosis Treatment Failure
Current Metabolomics Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design